InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (13 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
13
T+90 hit rate
67%
T+90 mean return
+1.9%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by GORMAN KEVIN CHARLES. Officer active across 2 companies, notably Neurocrine Biosciences INC. Cumulatively, 24 disclosures have been logged. Split: 1 buy · 13 sells. Total volume traded: €35.6m. History available since 7 February 2022. The latest transaction was disclosed on 16 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations24 total
10,302 shares0Common StockSEC:0001201096-26-000016:0
205,088 shares@ US$43.240.048% mcap15.4% of flowCommon StockSEC:0001201096-26-000010:0
245,088 shares@ US$154.33180.20% mcap65.5% of flowCommon StockSEC:0001201096-26-000010:1
5,376 shares0Common StockSEC:0000914475-25-000073:0
4,318 shares0Common StockSEC:0000914475-25-000052:0
5,141 shares0Common StockSEC:0000914475-25-000031:0
146,105 shares@ US$32.999.3% of flowCommon StockSEC:0000914475-25-000009:0
2,654 shares@ US$20.6898.1% of flowCommon StockSEC:0001127602-24-024672:0
5,986 shares0Common StockSEC:0001127602-24-018831:0
53 shares@ US$19.121.9% of flowCommon StockSEC:0001127602-24-005195:0
Ideal exit: 9 Nov 2024 (T+270)
2,832 shares@ US$133.01570.7% of flowCommon StockSEC:0000914475-24-000073:0
2,778 shares@ US$35.990.2% of flowCommon StockSEC:0000914475-24-000056:0
3,040 shares@ US$142.17710.8% of flowCommon StockSEC:0000914475-24-000046:0
2,707 shares@ US$140.68880.7% of flowCommon StockSEC:0000914475-24-000028:0
105,835 shares@ US$19.593.8% of flowCommon StockSEC:0000914475-24-000009:0
9,328 shares@ US$107.39881.8% of flowCommon StockSEC:0001209191-23-047137:0
5,007 shares0Common StockSEC:0001127602-23-019287:0
3,040 shares@ US$105.67720.6% of flowCommon StockSEC:0001209191-23-007912:0
2,707 shares@ US$110.08390.6% of flowCommon StockSEC:0001209191-23-006276:0
2,422 shares@ US$80.82520.0012% mcap50.0% of flowCommon StockSEC:0001209191-22-008211:0
2,422 shares@ US$80.82520.3% of flowCommon StockSEC:0001209191-22-008211
3,125 sharesCommon StockSEC:0001209191-16-095850:0
3,750 sharesCommon StockSEC:0001209191-16-092887:0
3,750 sharesCommon StockSEC:0001209191-16-091253:0
24 of 24 declarations
About GORMAN KEVIN CHARLES
GORMAN KEVIN CHARLES is a declarant who has filed a total of 23 filings. He is a director of Neurocrine Biosciences INC and Xencor Inc. In his most recent filings, he sold a total of 35,573,397 EUR, with the largest being 32,587,639.58 EUR on May 21, 2026, for Neurocrine Biosciences INC. The first filing was made on January 13, 2016, and the last on May 21, 2026.
